Fluorescence Lifetime Cross Correlation Spectroscopy Resolves EGFR and Antagonist Interaction in Live Cells
- 29 June 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 82 (15) , 6415-6421
Abstract
Fluorescence correlation or cross-correlation spectroscopy (FCS or FCCS), a single molecule technique, has the ability to provide highly sensitive information on interaction and dynamics of biomolecules both in vitro and in vivo. However, the inherent drawback of FCS is that species with similar molecular weight could not be differentiated. Although FCCS could resolve this through cross-correlation, it suffers from nonideal confocal volume overlap and spectral cross-talk which limits its application. In this work, we demonstrate for the first time the applicability of fluorescence lifetime correlation spectroscopy (FLCS) to monitor the interaction of an antagonist antibody with the epidermal growth factor receptor (EGFR) in live cells. As a proof of concept, we demonstrate the interaction of Cy5 labeled IgG and Alexa633 labeled anti-IgG using a single laser source (636 nm excitation) in vitro. The autocorrelation functions were separated based on their respective lifetime with a single detector and their Kd value was determined to be 11 ± 3 nM. An in vivo application constituting the interaction of EGFR neutralizing antibody labeled with Alexa488 and EGFR-GFP in live HEK293 cells was successfully demonstrated. The binding specificity of EGFR neutralizing antibody was confirmed by fluorescence lifetime cross-correlation measurements and fluorescence lifetime imaging (FLIM). The dissociation constant of this complex was found to be 9.2 ± 2.7 nM. A quantitative assessment of receptor density calculations show that the density of EGFR significantly decreased, from 540 ± 64 receptors/μm2 to 38 ± 7 receptors/μm2 upon addition of the neutralizing EGFR antibody, indicating that the antagonist could induce receptor internalization. The demonstrated work not only opens up new opportunities in studying protein−protein interactions in solutions and in live cells but also provide new insights in biology to understand how the antagonists influence EGFR through live cell quantification and imaging.Keywords
This publication has 43 references indexed in Scilit:
- siRNA Modifications and Sub-Cellular Localization: A Question of Intracellular Transport?Current Pharmaceutical Design, 2008
- Direct Gene Expression AnalysisCurrent Pharmaceutical Biotechnology, 2004
- Analysis of Biomolecular Interactions Using a Miniaturized Surface Plasmon Resonance SensorAnalytical Chemistry, 2002
- Benzodiazepine Binding Studies on Living Cells: Application of Small Ligands for Fluorescence Correlation SpectroscopyBiological Chemistry, 2002
- Molecular Brightness Characterization of EGFP In Vivo by Fluorescence Fluctuation SpectroscopyBiophysical Journal, 2002
- Accessing Molecular Dynamics in Cells by Fluorescence Correlation SpectroscopyBiological Chemistry, 2001
- Fluorescence Correlation Spectroscopy2001
- Fluorescence correlation spectroscopy: Diagnostics for sparse moleculesProceedings of the National Academy of Sciences, 1997
- Fluorescence correlation spectrometry of the interaction kinetics of tetramethylrhodamin α-bungarotoxin with Torpedo californica acetylcholine receptorBiophysical Chemistry, 1996
- Analysis of confocal laser-microscope optics for 3-D fluorescence correlation spectroscopyApplied Optics, 1991